Content about Peptide hormones

December 21, 2010
Novo Nordisk, Emisphere enter insulin deal

A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

December 20, 2010
Amylin's lipodystrophy treatment granted orphan-drug, fast-track designations

Drug maker Amylin Pharmaceuticals has submitted the first of a series of sections of a regulatory approval application for a biotech drug to treat patients with a rare lipid disorder.

December 9, 2010
Combining Lilly and Amylin drug with insulin intake found to promote weight loss

Combining a diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals controls blood sugar and promotes weight loss more than insulin alone, according to a new study.

November 15, 2010
JDRF, Amylin support clinical proof-of-concept study

A leading charitable funder of and advocate for Type 1 diabetes research and a drug...

November 7, 2010
Study finds GLP-1 analogues may improve blood-glucose levels, BMI

A new study conducted by University of Toronto researchers found that GLP-1 analogues not only...

November 2, 2010
Biodel receives complete response letter for Linjeta

The Food and Drug Administration has turned down an application for an insulin product made...

November 2, 2010
Lilly CEO: 'New approaches' must be found to combat diabetes

The CEO of drug maker Eli Lilly has called for a “wave of invention” to...

October 19, 2010
FDA declines to approve Bydureon

The Food and Drug Administration declined to approve a long-anticipated diabetes drug made by Eli...

October 17, 2010
Pfizer inks deal with Biocon

Pfizer has entered the world of biosimilars through a deal with India-based Biocon to distribute...

September 19, 2010
Sanofi-Aventis: Lantus provides further blood-sugar reduction for patients with Type 2 diabetes

An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar...

September 19, 2010
Sanofi-Aventis: Lixisenatide aids blood-glucose control for Type 2 diabetics

An investigational treatment made by French drug maker Sanofi-Aventis showed “significant” improvement in blood-glucose control...

August 29, 2010
Novo Nordisk launches NovoDose

Novo Nordisk has launched a mobile dosing app for healthcare professionals that prescribe the drug...

August 15, 2010
JDRF announces insulin initiative for artificial pancreas program

The Juvenile Diabetes Research Foundation has expanded its artifical pancreas program with an initiative that...

June 24, 2010
Metabolex, Sanofi-Aventis announce new partnership

French drug maker Sanofi-Aventis has made a deal with U.S. drug maker Metabolex to license...

June 21, 2010
Generex to exhibit at ADA meeting

Generex Biotechnology Corp. will be among the companies exhibiting at an upcoming American Diabetes Association...

June 20, 2010
Roche implements risk-mitigation plan for taspoglutide

Swiss drug maker Roche has started a risk-mitigation plan in the late-stage clinical trial of...

June 8, 2010
Unigene appoints new CEO

Unigene Labs has appointed a new leader, the company said Wednesday....

May 31, 2010
Amylin announces leadership changes

Amylin has named a new SVP research and development and SVP and chief medical officer,...

May 2, 2010
Novo Nordisk launches online contest for insulin pen users

Novo Nordisk is asking diabetics to show off how they flex -- their insulin pens....

March 29, 2010
Study finds Victoza more effective in treating Type 2 diabetes than competitor

A study published online in the journal Diabetes Care indicated that a once-daily diabetes drug...

February 16, 2010
Novo Nordisk announces new once-daily treatment for Type 2 diabetes

A new injectable Novo Nordisk drug for diabetes is on the shelves, the Danish drug...

February 10, 2010
Biodel presents clinical trial results of VIAject at conference

A specialty biopharmaceutical company focused on endocrine disorder treatments will present results of two phase...

February 10, 2010
Roche to expand diabetes pipeline

Diabetes patients may soon find themselves with an expanded range of treatment options....

January 25, 2010
Decision Resources projects proprietary clinical gold standard status for Byetta

WALTHAM, Mass. A once-weekly treatment for Type 2 diabetes will likely become a popular treatment...

January 25, 2010
FDA approves Novo Nordisk's Victoza for Type 2 diabetes

The Food and Drug Administration has approved a long-awaited treatment for Type 2 diabetes, the...

© 2013 Drug Store News. All Rights Reserved.